Pacific Biosciences of California, Inc. (PACB) Cash Flow Statement
Pacific Biosciences of California, Inc. (PACB) generated -$118.0M of operating cash flow over the twelve months to 2026-06-30, spent $5.4M on capital expenditure and had free cash flow of -$123.4M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PACBPacific Biosciences of California, Inc.Follow PACB — free
—
Price chart with a free account
- Market cap
- 655.9M
- P/E TTM
- —
- Dividend yield
- 0.0%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.10 | -0.08 | -0.03 | -0.05 | -0.05 | -0.07 | -0.07 | -0.07 | -0.08 | 0.02 | -0.11 | -0.26 | -0.26 | -0.21 | -0.11 | -0.12 | |
| Capital expenditure | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.01 | 0.01 | 0.00 | -0.01 | |
| Free cash flow | -0.11 | -0.08 | -0.03 | -0.05 | -0.05 | -0.08 | -0.08 | -0.07 | -0.08 | 0.02 | -0.12 | -0.28 | -0.27 | -0.21 | -0.11 | -0.12 | |
| Stock-based compensation | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.07 | 0.08 | 0.07 | 0.07 | 0.04 | — |
USD billions · SEC XBRL
Pacific Biosciences of California, Inc. — questions
- What is Pacific Biosciences of California, Inc.'s operating cash flow?
- -$118.0M over the twelve months to 2026-06-30.
- How much does Pacific Biosciences of California, Inc. spend on capital expenditure?
- $5.4M over the twelve months to 2026-06-30.
- What is Pacific Biosciences of California, Inc.'s free cash flow?
- -$123.4M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Pacific Biosciences of California, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.